💊 Geftinat 250 mg Tablet | Gefitinib | Lung Cancer Treatment | Export Supplier
Geftinat 250 mg Tablet contains Gefitinib, a targeted anticancer medicine used in the treatment of non-small cell lung cancer (NSCLC). It works by inhibiting the EGFR pathway, helping to slow down cancer cell growth and progression, especially in patients with EGFR mutations.
🔹 Product Category
Oncology Medicine (Targeted Therapy / EGFR Inhibitor)
🔹 Composition
Gefitinib 250 mg
🔹 Indications
✔ Non-Small Cell Lung Cancer (NSCLC)
✔ EGFR Mutation-Positive Cases
🔹 Key Benefits
✔ Targeted therapy (EGFR inhibitor)
✔ Effective in mutation-specific patients
✔ Oral treatment (patient-friendly)
✔ Widely used in oncology protocols
🔹 Dosage & Administration
✔ Oral tablet as prescribed
✔ Can be taken with or without food
✔ Dosage based on patient condition
✔ Under strict medical supervision
🔹 Packaging
✔ Blister / Bottle Packaging
✔ Bulk Export Available
✔ Private Labeling Supported
🔹 Certifications
✔ WHO-GMP Certified
✔ COA & COPP Available
🌍 Target Export Markets & Cities
🇺🇸 USA: New York, Los Angeles, Houston
🇬🇧 UK: London, Manchester
🇦🇪 UAE: Dubai, Abu Dhabi
🇸🇬 Singapore: Singapore
🇮🇳 India: Mumbai, Delhi, Bangalore
🇵🇭 Philippines: Manila
🇻🇳 Vietnam: Ho Chi Minh City, Hanoi
🇿🇦 South Africa: Johannesburg, Cape Town
🇳🇬 Nigeria: Lagos, Abuja
🇰🇪 Kenya: Nairobi
🇧🇷 Brazil: São Paulo
🇲🇽 Mexico: Mexico City
🇵🇪 Peru: Lima
📍 Location: Nagpur, Maharashtra, India
📦 Product Catalogue Available
✔ Oncology Medicines
✔ HIV & Antiviral Medicines
✔ Specialty Pharmaceutical Products
📞 Instant Support – Call / WhatsApp Now
📲 +91 8007161282
📲 +91 9970011496
💬 Quick replies for urgent orders & inquiries!
🌐 Visit Our Official Websites
🔹 www.pacificmedicines.com
🔹 www.indocares.com
🔹 www.indiamedexport.com
📧 Business Enquiries & Bulk Orders
